Acrocyte Therapeutics

AcroCyte Therapeutics is a cell-based precision medicine company that utilizes R3CE (Rapid, Reproducible, Rare Cell Expansion), a scaffold-free 3D cell culture technology, to revolutionize drug development and personalized cancer treatment. The platform enables researchers and clinicians to expand and study patient-derived cells in conditions that closely mimic in vivo biology, bridging the gap between laboratory models and real-world therapeutic outcomes. With operations in Taiwan and the United States, AcroCyte partners with research institutions and pharmaceutical companies to advance precision oncology and reduce reliance on animal models.